HSPA5 and colorectal cancer: La et al. also proved that 50 μM EGCG increased DLD1 colorectal cancer cell line’s sensitivity to 5-FU through the inhibition of 78-kDa glucose-regulated protein (GRP78), NF-KB, miR-155-p5, and multidrug resistance mutation 1 (MDR1) pathways [122].